Insider · CIK 0001684258
Jane A Gross
director
Files at ATYR (aTYR PHARMA INC). First filing Mar 17, 2025, latest Mar 17, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$15k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ATYR: aTYR PHARMA INC
ATYROct 9, 2026 · close 0.25
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 1, 2025 | ATYR aTYR PHARMA INC | AGrant or award Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | May 2, 2025 |
| Mar 17, 2025 | ATYR aTYR PHARMA INC | POpen-market purchase Common Stock | +3,750 | $4.00 | $15k | 9,750 | Mar 17, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.